HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab.

AuthorsAndrea Tendas, Pasquale Niscola, Laura Scaramucci, Luca Cupelli, Alessio Pio Perrotti, Paolo de Fabritiis
JournalBlood research (Blood Res) Vol. 51 Issue 2 Pg. 137-8 (Jun 2016) ISSN: 2287-979X [Print] Korea (South)
PMID27382560 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: